Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Cilnidipine/Valsartan FDC vs Coadministration
NCT02343250Phase 1Completed
- Sponsor
- Ildong Pharmaceutical Co Ltd
- Start
- Mar 2015
- Primary completion
- Mar 2015
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of cilnidipine and valsartan in hypertension (HTN) (2 arms), sponsored by Ildong Pharmaceutical Co Ltd. Primary endpoints: Area Under the Curve from time zero to last measurable concentration and Maximum Plasma Concentration. Started Mar 2015; status: completed.
02
Drugs
cilnidipinevalsartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02343250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02343250.